MedTrace Logo

Intertrochanteric Femoral Fracture Fixation Trial

NCT02627040 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2019-11-18

No results posted yet for this study

Summary

The main goal of the study is to determine which cephalomedullary nail results in a better functional outcome for the patient with an unstable intertrochanteric hip fracture. Subjects will be randomized to fixation with either a Gamma3 cephalomedullary nail or an InterTan cephalomedullary nail. Outcomes will be reviewed over a 12 month follow-up period.

Conditions

  • Intertrochanteric Fracture
  • Hip Fracture

Interventions

DEVICE

InterTan Intertrochanteric Nail

Cephalomedullary fixation of intertrochanteric fracture with an InterTan Intertrochanteric Nail

DEVICE

Gamma 3 Intertrochanteric Nail

Cephalomedullary fixation of intertrochanteric fracture with an Gamma 3 Intertrochanteric Nail

Sponsors & Collaborators

  • Florida Orthopaedic Institute

    lead NETWORK

Principal Investigators

  • Hassan R Mir, MD, MBA · Florida Orthopaedic Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2020-08-31
Completion
2020-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02627040 on ClinicalTrials.gov